Key result
Antiplatelet agents, including aspirin, ticlopidine, and emerging GPIIb/IIIa inhibitors, are important therapeutic options for the prevention and treatment of vaso-occlusive thrombosis.
Design
Review
Authors
Loading...
Supports antiplatelet options in thrombosis; leaves open comparative efficacy of emerging GPIIb/IIIa inhibitors.
The review summarizes the role of existing antiplatelet agents like aspirin and ticlopidine while highlighting the development of more potent GPIIb/IIIa inhibitors for thrombosis.
Barry S. Coller (1992) conducted a review in Vaso-occlusive thrombosis. Antiplatelet agents (aspirin, ticlopidine, GPIIb/IIIa inhibitors) was evaluated. Antiplatelet agents, including aspirin, ticlopidine, and emerging GPIIb/IIIa inhibitors, are important therapeutic options for the prevention and treatment of vaso-occlusive thrombosis.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: